These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35087470)

  • 1. Parkinson's Disease With Visual Hallucinations Is Associated With Epileptiform Activity on EEG.
    Fry A; Singh D; Manganas L; Gordon ML; Christodoulou C; Leung HC; Schwartz GJ
    Front Neurol; 2021; 12():788632. PubMed ID: 35087470
    [No Abstract]   [Full Text] [Related]  

  • 2. Categorising Visual Hallucinations in Early Parkinson's Disease.
    Clegg BJ; Duncan GW; Khoo TK; Barker RA; Burn DJ; Yarnall AJ; Lawson RA
    J Parkinsons Dis; 2018; 8(3):447-453. PubMed ID: 30040741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients.
    Ferrari M; Comi C; Marino F; Magistrelli L; De Marchi F; Cantello R; Riboldazzi G; Bono G; Cosentino M
    Eur J Clin Pharmacol; 2016 Nov; 72(11):1335-1341. PubMed ID: 27497990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible Contribution of Altered Cholinergic Activity in the Visual Cortex in Visual Hallucinations in Parkinson's Disease.
    Sinclair L; Brenton J; Liu AKL; MacLachlan R; Gentleman SM; Love S
    J Neuropsychiatry Clin Neurosci; 2022; 34(2):168-176. PubMed ID: 34961331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for visual hallucinations in patients with Parkinson's disease.
    Gama RL; de Bruin VM; de Bruin PF; Távora DG; Lopes EM; Jorge IF; Bittencourt LR; Tufik S
    Neurol Res; 2015 Feb; 37(2):112-6. PubMed ID: 25002179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventral striatal dopaminergic defect is associated with hallucinations in Parkinson's disease.
    Jaakkola E; Joutsa J; Mäkinen E; Johansson J; Kaasinen V
    Eur J Neurol; 2017 Nov; 24(11):1341-1347. PubMed ID: 28834102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The yield of preoperative sequential routine scalp EEGs in patients who underwent anterior temporal lobectomy for mesial temporal sclerosis.
    Dericioglu N; Colpak AI; Ciger A; Saygi S
    Clin EEG Neurosci; 2010 Jul; 41(3):166-9. PubMed ID: 20722353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease.
    Manganelli F; Vitale C; Santangelo G; Pisciotta C; Iodice R; Cozzolino A; Dubbioso R; Picillo M; Barone P; Santoro L
    Brain; 2009 Sep; 132(Pt 9):2350-5. PubMed ID: 19584099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4-year study.
    Gibson G; Mottram PG; Burn DJ; Hindle JV; Landau S; Samuel M; Hurt CS; Brown RG; M Wilson KC
    Int J Geriatr Psychiatry; 2013 Jun; 28(6):626-31. PubMed ID: 22927195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin 2A receptors and visual hallucinations in Parkinson disease.
    Ballanger B; Strafella AP; van Eimeren T; Zurowski M; Rusjan PM; Houle S; Fox SH
    Arch Neurol; 2010 Apr; 67(4):416-21. PubMed ID: 20385906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural brain abnormalities in patients with Parkinson's disease with visual hallucinations: a comparative voxel-based analysis.
    Gama RL; Bruin VM; Távora DG; Duran FL; Bittencourt L; Tufik S
    Brain Cogn; 2014 Jun; 87():97-103. PubMed ID: 24732953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caudate dopaminergic denervation and visual hallucinations: evidence from a ¹²³I-FP-CIT SPECT study.
    Kiferle L; Ceravolo R; Giuntini M; Linsalata G; Puccini G; Volterrani D; Bonuccelli U
    Parkinsonism Relat Disord; 2014 Jul; 20(7):761-5. PubMed ID: 24787757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between visual hallucinations and REM sleep behavior disorder in patients with Parkinson's disease.
    Meral H; Aydemir T; Ozer F; Ozturk O; Ozben S; Erol C; Cetin S; Hanoglu L; Ozkayran T; Yilsen M
    Clin Neurol Neurosurg; 2007 Dec; 109(10):862-7. PubMed ID: 17913346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beneficial effect of donepezil on visual hallucinations in three patients with Parkinson's disease.
    Kurita A; Ochiai Y; Kono Y; Suzuki M; Inoue K
    J Geriatr Psychiatry Neurol; 2003 Sep; 16(3):184-8. PubMed ID: 12967063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What associates Charles Bonnet syndrome with age-related macular degeneration?
    Vojniković B; Radeljak S; Dessardo S; Zarković-Palijan T; Bajek G; Linsak Z
    Coll Antropol; 2010 Apr; 34 Suppl 2():45-8. PubMed ID: 21305724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual loss and visual hallucinations in patients with age-related macular degeneration (Charles Bonnet syndrome).
    Abbott EJ; Connor GB; Artes PH; Abadi RV
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1416-23. PubMed ID: 17325191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hallucinations and sleep disturbances in Parkinson's disease.
    Kulisevsky J; Roldan E
    Neurology; 2004 Oct; 63(8 Suppl 3):S28-30. PubMed ID: 15505140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep learning for detection of focal epileptiform discharges from scalp EEG recordings.
    Tjepkema-Cloostermans MC; de Carvalho RCV; van Putten MJAM
    Clin Neurophysiol; 2018 Oct; 129(10):2191-2196. PubMed ID: 30025804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroencephalographic-Based Functional Connectivity Networks of Visual Hallucinations and Visuospatial Dysfunctions in Parkinson's Disease.
    Kinugawa K; Mano T; Takatani T; Kido A; Sugie K
    Eur Neurol; 2022; 85(5):404-409. PubMed ID: 35483334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epileptic activity of the occipital lobe. Clinico-electroencephalographic contribution].
    Schäffler L; Karbowski K
    Fortschr Neurol Psychiatr; 1988 Sep; 56(9):286-99. PubMed ID: 3220420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.